Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2022 04:18 ET | Source: Research and Markets

Global Viral and Non-Viral Vector Manufacturing Market 2022: Favorable Funding Scenario for Vector-Based Therapies | Rapid Uptake of Viral Vector to Develop Innovative Therapies

Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and Region - Analysis and Forecast, 2021-2031"...
December 15, 2021 09:03 ET | Source: Research and Markets

Global Targeted Therapeutics Market Research Report 2021: Market will Surpass $100+ Billion in 2021 - Forecast to 2026

Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Targeted Therapeutics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for targeted...
November 11, 2021 04:43 ET | Source: Research and Markets

Worldwide Genetic Testing Industry to 2027 - by Type Technology, Application and Region

Dublin, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The "Genetic Testing Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to...
May 14, 2021 09:03 ET | Source: Research and Markets

Global Genomics in Cancer Care Market Report 2021: Market to Reach $66.6 Billion by 2027 - Instruments Segment is Projected to Account for $26.9 Billion of the Total Market

Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Genomics in Cancer Care - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Genomics in...
March 31, 2021 06:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics and StemoniX Announce Merger Closing

Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT CHERRY HILL, N.J., March 31, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc....
March 18, 2021 08:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development

RUTHERFORD, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today the appointment of...
March 12, 2021 09:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Present at the Annual 33rd ROTH Conference

RUTHERFORD, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts,...
March 04, 2021 16:15 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference

RUTHERFORD, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts,...
February 17, 2021 05:48 ET | Source: Research and Markets

Global Viral Vector & Plasmid DNA Manufacturing Market Report 2021 - Rising Use of Viral Vectors in Several Treatments Demands Developments in Plasmids and Vectors

Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Workflow, by Application, by End User - Global Forecast to 2025 -...
February 10, 2021 23:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules

RUTHERFORD, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...